Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akanda Corp AKAN

Healthcare
Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United... see more

Recent & Breaking News (NDAQ:AKAN)

Akanda Corporation Has Regained Compliance with NASDAQ's Minimum Bid Price Requirement

Business Wire March 29, 2023

Akanda Corporation Announces 1-for-10 Reverse Stock Split

Business Wire March 8, 2023

Akanda Corporation Announces CFO Appointment

Business Wire March 7, 2023

Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director

Business Wire February 16, 2023

Akanda Corp.'s Chief Executive Officer Submits Resignation

Business Wire February 7, 2023

Akanda Books €1.8M of Revenue in Q4 2022 As German Sales Start

Business Wire February 2, 2023

Akanda Corp.'s Chief Executive Officer On Paid Leave of Absence

Business Wire December 21, 2022

Akanda Targets 10% of German Medical Cannabis Market with its Premium Flower Cultivation Operations in Portugal

Business Wire November 16, 2022

Halo Collective Reports Third Quarter 2022 Financial Results

Canada NewsWire November 14, 2022

Akanda Announces Arrival of First Shipment and Sales of Medical Cannabis to Germany

Business Wire November 8, 2022

Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Business Wire October 3, 2022

Akanda Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position

Business Wire September 26, 2022

Akanda Partners with Cookies to Bring the Iconic Cannabis Brand and High THC Strains to European Consumers for the First Time

Business Wire September 13, 2022

Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board

Business Wire September 8, 2022

Akanda to Participate in Benzinga Cannabis Capital Conference International Panel on September 13, 2022

Business Wire September 7, 2022

Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe

Business Wire August 24, 2022

Akanda to Supply Cansativa with Premium Indoor Cannabis Flower Grown at its Sintra Facility in Portugal

Business Wire August 9, 2022

Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany

Business Wire August 9, 2022

Akanda to Contest Unauthorized Liquidation of its Lesotho-Based Subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd.

Business Wire July 26, 2022

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF(TM), a Potential Multimillion Dollar Prescription Drug

PR Newswire July 12, 2022